ACCESS TO CAPITAL
More than funding —
a partner in building value
Access to capital is critical in life sciences. But capital alone is not enough.
We combine investment with active support, helping companies build structure,
reduce risk and focus on what creates long-term value.
At the same time, we open the door to a strong network of investors and funding
partners — ensuring that companies are prepared and positioned for the next step.
Access to Capital
What we do
We invest in selected early-stage companies with strong scientific foundation
We support companies in preparing for investment and financing processes
We connect ventures with relevant investors and funding partners
We provide access to a trusted network across the life science ecosystem
Access to Capital
Our approach
We are selective in where we engage.
Our focus is on companies where we can contribute — not only with capital, but with experience, structure and long-term perspective.
We support companies through key funding milestones.
We invest early and stay engaged.
We prioritise quality and long-term potential.